Home bam

Personalised Medicine News

UCL receives largest share of NHS research funding

UCL’s three biomedical research centres (BRCs) have won more than £167 million in funding from the National Institute for Health Research (NIHR) to further world-leading biomedical research conducted with partner hospitals. UCL has received more funding than any other UK university, followed by King's College London and Oxford University, which received £133m and £127m respectively.

Published: Sep 14, 2016 2:58:18 PM

Science begins in the new Francis Crick Institute building

The first scientists have moved into the new £650 million Francis Crick Institute building in London and are starting work in their purpose-built labs. Next to St Pancras station and the British Library, the Crick will be the biggest biomedical research institute under one roof in Europe.

Published: Sep 1, 2016 10:32:32 AM

Refining the genetic causes of schizophrenia

An international study involving UCL has made advances in understanding the ways in which genetic risk factors alter gene function in schizophrenia.

Published: Aug 30, 2016 3:34:22 PM

Heart drug could reduce diabetes related blindness

Researchers at UCL and Queen’s University Belfast have discovered that a drug originally developed to treat cardiovascular disease has the potential to reduce diabetes related blindness.

Published: Jun 14, 2016 1:02:15 PM

Cancer drugs could target autoimmune diseases

Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition in mice at UCL and King’s College London.

Published: Jun 10, 2016 4:18:28 PM

New team to develop radiotherapies that target cancer more effectively

Safer precision radiotherapies that will be able to cure more cancers with fewer side-effects will be available within five years under ambitious new plans for research and treatment at the UCL Cancer Institute and University College London Hospitals (UCLH) NHS Foundation Trust.

Published: Apr 22, 2016 9:36:29 AM

Cancer drug could treat blood vessel deformities

A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin, finds new research in mice led by UCL, Memorial Sloan Kettering (MSK) Cancer Center in New York and the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona.

Published: Mar 31, 2016 12:48:52 PM

New drug shows promise against muscle wasting disease

A new drug to treat the muscle wasting disease inclusion body myositis (IBM) reverses key symptoms in mice and is safe and well-tolerated in patients, finds a new study led by the Medical Research Council (MRC) Centre for Neuromuscular Diseases at UCL and the University of Kansas Medical Center.

Published: Mar 24, 2016 9:19:13 AM

Tumours contain the seeds of their own destruction

Scientists at UCL have made a groundbreaking discovery in understanding how the genetic complexity of tumours can be recognised and exploited by the immune system, even when the disease is at its most advanced stages.

Published: Mar 4, 2016 9:35:45 AM

Resistance to key HIV drug ‘concerningly common’

HIV drug resistance to tenofovir, an antiretroviral drug vital to most modern HIV treatment and prevention strategies, is surprisingly and worryingly common according to a large study led by UCL and funded by the Wellcome Trust.

Published: Jan 29, 2016 10:02:47 AM

View all articles